| Literature DB >> 35566645 |
Rebekah Moore1, David Gillanders2, Simon Stuart3.
Abstract
Emotional regulation (ER) as a concept is not clearly defined, and there is a lack of clarity about how individuals can improve their ability to regulate emotions. Nevertheless, there is increasing evidence of the importance of ER as a transdiagnostic treatment target across mental health problems. This review examines the impact of ER group interventions on ER ability compared with no intervention, other comparable group interventions, or control conditions. A systematic review was conducted, in which 15 studies were included. Although types of ER intervention were mixed, the interventions had a considerable overlap in skills taught and how ER was measured. In all but one study, the ER intervention improved ER ability. ER interventions were superior to waitlist or treatment as usual, but there was limited evidence to suggest they were superior to other active treatments. Data from some studies suggest that improved ER was sustained at follow-up. Across the studies, there was generally poor linking of theory to practice, which hampers understanding of how interventions were constructed and why different skills were included. Although the results need to be interpreted with caution due to issues with methodological quality with the included papers, there is promising evidence that ER group interventions significantly improve ER ability.Entities:
Keywords: emotion dysregulation; emotion regulation; evidence-based practice; group intervention
Year: 2022 PMID: 35566645 PMCID: PMC9105582 DOI: 10.3390/jcm11092519
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1PRISMA 2009 Flow Diagram [55].
Summary of study characteristics.
| Study | Design | Intervention(s) | Intervention Duration | Study Population and Demographics | Sample Size and Gender | Data Used for Analysis | Data Collection Points |
|---|---|---|---|---|---|---|---|
| Bacon et al. (2018) | Before and after Randomisation: No | 1. Semi-manualized ER group programme | 6 weeks, 150 min each session | Patients attending routine secondary care mental health services, variety of diagnoses | Total data sets analysed | Pre and post intervention | |
| Berking et al. (2019) | Randomised control trial (RCT) | 1. Affect regulation training (ART) | 6 weeks, 180 min each session, then four weeks of independent skills practise and one 90 min booster session on week 8 | Diagnosis of major depressive disorder | Total data sets analysed | Pre, mid, mid, post intervention | |
| Corpas et al. (2021) | Randomised control trial (RCT) | 1. Brief Group Transdiagnostic Psychotherapy (based on UP protocol) | 8 weeks, 60 min each session | Mild/moderate | Total data sets analysed | Pre and post intervention | |
| Dixon-Gordon et al. (2015) | Pilot study | 1. DBT-ER (ER skills only) | 6 weeks, no information on session length | Women with Borderline Personality Disorder (BPD) | Total data sets analysed | Pre, mid and post intervention | |
| Ford et al. (2014) | RCT | 1. Trauma Affect Regulation: | 12 weeks, 75 min each session | Women in prison with full or partial | Total data sets analysed | Pre and post intervention | |
| Gratz & Gunderson (2006) | RCT | 1. Acceptance-based emotion regulation group intervention (ERGT) and treatment as usual (TAU) | 14 weeks, 90 min each session | Women with BPD who self-harm | Total data sets analysed | Pre and post intervention | |
| Gratz & Tull (2011) | Before and after | 1. ERGT and TAU | 14 weeks, 90 min each session | Women who self-harm with either threshold or subthreshold | Total data sets analysed | Pre and post intervention | |
| Gratz et al. (2014) | RCT and uncontrolled 9-month follow-up | 1. ERGT and TAU | 14 weeks, 90 min each session | Female out-patients who self-harm with either threshold or subthreshold | Total data sets analysed | Pre and post intervention | |
| Holmqvist Larsson et al. (2020) | Before and after | 1. Emotion regulation skills training. Based on ERGT, UP, DBT and ACT | 5 weeks, 120 min each session | Female out-patients with eating disorders | Total data sets analysed | Pre and post intervention | |
| Morvaridi et al. | Quasi-experimental | 1. Emotional schema therapy (Leahy, 2015) | 10 weeks, 120 min each session | Women with social anxiety | Total data sets analysed | Pre and post intervention | |
| Rizvi & Steffel | Before and after | 1. ER skills training from DBT modules | 8 weeks, 120 min each session | Undergraduates with significant problems with emotional regulation | Total data sets analysed | Pre, mid and post intervention | |
| Ryan et al. (2021) | Before and after | 1. Living through psychosis (LTP) | 8 sessions over 4 weeks. First session was 300 min and subsequent sessions were 180 min | People with a psychotic disorder diagnosis at an independent psychiatric hospital | Total data sets analysed | Baseline, pre, post and follow-up | |
| Sahlin et al. (2017) | Before and after | 1. ERGT | 14 weeks, 120 min each session | Women at 14 psychiatric outpatient clinics meeting 3 or more diagnostic criteria for BPD and 3 or more episodes of DSH in last 6 months | Total data sets analysed | Pre and post intervention | |
| Varkovitzky et al. (2018) | Observational case series | 1. Unified protocol (UP) for the transdiagnostic treatment of emotional | 16 weeks, 90 min each session | Patients at PTSD outpatient clinic for veterans | Total data sets analysed | Pre and post intervention | |
| Zargar et al. (2019) | RCT | 1. ERGT +TAU | 8 weeks, 120 min each session | Male patients admitted to addiction centre with substance use disorder | Total data sets analysed | Pre and post intervention |
Summary of treatment effects on ER outcome measure.
| Study | ER Measure | Pre Mean (SD) | Post Mean (SD) | Effect Size(s) and/or Summary of Results | Were Changes in ER Accompanied by Other Clinically Relevant Changes? |
|---|---|---|---|---|---|
| Studies with active control conditions ( | |||||
| Berking et al. (2019) | ERSQ | ART 1.72 (0.66) | ART 2.18 (0.65) | Within Participants | Yes—depressive symptoms also reduced—significantly larger reduction in ART compared to WLC. However no significant differences in symptom reduction between ART and CFC. |
| Dixon-Gordon et al. (2015) | DERS | DBT-ER | DBT-ER | Within Participants | Yes—improvements in a range of other domains: interpersonal skills, distress tolerance, mindfulness, BPD symptoms, depressive symptoms and non suicidal self-injury |
| Ford et al. (2014) | NMR | TARGET | TARGET | Within Participants | Yes—reduction in PTSD and trauma symptoms and general distress (as measured by CORE-OM) |
| Rizvi & Steffel (2014) | DERS | DBT-ER | DBT-ER | Within Participants | Yes—improvements in depression and stress |
| Studies with waitlist or TAU control | |||||
| Corpas et al. (2021) | Emotion Regulation Questionnaire (ERQ) | UP | UP | Within Participants | Yes—reductions on scores of anxiety and reduced number of people meeting criteria for diagnosis for a range of mental health problems. |
| Gratz et al. (2014) | DERS | ERGT + TAU | ERGT + TAU | Within Participants | Yes—significant improvements on deliberate self-harm, BPD symptoms, depression, stress and quality of life |
| Gratz & Gunderson (2006) | DERS | ERGT + TAU | ERGT + TAU | Within Participants | Yes—positive effects on self-harm, experiential avoidance, BPD symptoms, depression, anxiety and stress |
| Morvaridi et al. (2019) | (ERQ) | EST | EST | Within Participants | Yes—reduced anxiety symptoms |
| Zargar et al. (2019) | DERS | ERGT(G) + TAU | ERGT(G) + TAU | Within Participants | Yes—improved martial adjustment, decreased cravings |
| Studies with no control | |||||
| Bacon et al. (2018) | DERS | ERG | ERG | Within Participants | Yes—significant improvements in self-efficacy and mental wellbeing |
| Gratz & Tull (2011) | DERS | ERGT | ERGT | Within Participants | Yes—improvements in deliberate self-harm, experiential avoidance and psychiatric symptoms |
| Holmqvist Larsson et al. (2020) | DERS | ERST | ERST | Within Participants | Yes—improvement in alexithymia and reduction in eating disorder symptoms and clinical impairment |
| Ryan et al. (2021) | DERS | LTP | LTP | Within Participants | Yes—reduction in hallucinations, delusion severity and distress, increase in recovery scale and mindfulness scale |
| Sahlin et al. (2017) | DERS | ERGT | ERGT | Within Participants | Yes—reduction in self-harm frequency, other self-destructive behaviours and general psychiatric symptoms |
| Varkovitzky et al. (2018) | DERS | UP | UP | Within Participants | Yes—improvements in PTSD and depressive symptoms |
Notes: a = Effect size calculated by first author; ART = Affect regulation training; CFC = Common factors control condition; SGT = Supportive group therapy; TAU = Treatment as normal; WLC = Waitlist control condition; ERGT = Emotion regulation group therapy; ERGT(G) = Emotion regulation group therapy based on Gross model; ERG = Emotional resources group; UP = Unified protocol for transdiagnostic treatment of emotional disorders; ERST = Emotion regulation skills training; EST = Emotional schema therapy; DBT-ER = Dialectical Behaviour Therapy–Emotion regulation skills module; DBT-MF+ER = Dialectical Behaviour Therapy–Mindfulness and emotion regulation skills modules; DBT-IE = Dialectical Behaviour Therapy–Interpersonal effectiveness skills module; IPE = psychoeducation group; LTP = Living Through Psychosis group programme; DERS = Difficulties in emotion regulation scale; ERSQ = Emotion Regulation Skills Questionnaire; NMR = Generalized Expectancies for Negative Mood Regulation; ns = not significant, p > 0.05. The effect sizes for Cohen’s d and Hedges g are the following: 0.2 represents a “small” effect size, 0.5 represents a “medium” effect size, and 0.8 represents a “large” effect size. The effect sizes for partial eta squared np2 and eta squared n2 are the following: 0.01 represents a small effect size, 0.06 represents a moderate effect size, and 0.14 represents a large effect size.
Downs and Black Modified Checklist.
| Reporting | |
|---|---|
| 1. Is the hypothesis/aim/objective of the study clearly described? | Yes = 1, No = 0 |
| 2. Are the main outcomes clearly described in the Introduction or Methods? | Yes = 1, No = 0 |
| 3. Are characteristics of the patients included in the study clearly described? | Yes = 1, No = 0 |
| 4. Are the interventions clearly described? | Yes = 1, No = 0 |
| 5. Are there clear theory to practise links that justify the use of the specific intervention to improve ER? a | Yes = 2, Partially = 1, Unclear = 0, No = 0 |
| 6. Are any other interventions participants are receiving clearly described? a e.g., other therapeutic input | Yes = 1, Unclear = 0, No = 0 |
| 7. Are the distributions of principal confounders in each group of subjects clearly described? | Yes = 2, Partially = 1, No = 0 |
| 8. Are the main findings of the study clearly described? | Yes = 1, No = 0 |
| 9. Does the study estimate random variability in data for main outcomes? | Yes = 1, No = 0 |
| 10. Have all the important adverse events consequential to the intervention been reported? | Yes = 1, No = 0 |
| 11. Have characteristics of patients lost to follow-up been described? | Yes = 1, No = 0 |
| 12. Have actual probability values and effect sizes been reported for the main outcomes except probability <0.001? | Yes = 1, No = 0 |
| 13. Is the source of funding clearly stated? a | Yes = 1, No = 0 |
|
| |
| 14. Were subjects who were asked to participate in the study representative of the entire population recruited? | Yes = 1, No = 0, Unable to determine = 0 |
| 15. Were those subjects who were prepared to participate representative of the recruited population? | Yes = 1, No = 0, Unable to determine = 0 |
| 16. Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? | Yes = 1, No = 0, Unable to determine = 0 |
|
| |
| 17. Was an attempt made to blind those measuring the main outcomes? | Yes = 1, No = 0, Unable to determine = 0 |
| 18. Were analyses planned apriori, pre-registered on a public website, and the analysis plan followed? a | Yes = 1, No = 0, Unable to determine = 0 |
| 19. Was the time period between intervention and outcome the same for intervention and control groups or adjusted for? | Yes = 1, No = 0, Unable to determine = 0 |
| 20. Were the statistical tests used to assess main outcomes appropriate? | Yes = 1, No = 0, Unable to determine = 0 |
| 21. Was compliance with the interventions reliable? a | Yes = 1, No = 0, Unable to determine = 0 |
| 22. Is there evidence that the intervention was delivered as intended? a
| Yes = 1, No = 0, Unable to determine = 0 |
| 23. Were main outcome measures used accurate? (valid and reliable) | Yes = 1, No = 0, Unable to determine = 0 |
|
| |
| 24. Were patients in different intervention groups recruited from the same population? | Yes = 1, No = 0, Unclear = 0 |
| 25. Were study subjects in different intervention groups recruited over the same period of time? | Yes = 1, No = 0, Unclear = 0 |
| 26. Were study subjects randomized to intervention groups? | Yes = 1, No = 0, Unclear = 0 |
| 27. Was an appropriate method of randomisation described? a | Yes = 1, No = 0, Unclear = 0 |
| 28. Were attempts made to assess groups equivalence at baseline? a
| Yes = 1, No = 0, Unclear = 0 |
| 29. Are any other interventions participants are receiving adequately controlled for? | Yes = 1, Unclear = 0, No = 0 |
| 30. Was there an adequate control group? b | Yes = 1, No = 0, Unclear = 0 |
| 31. Was the randomized intervention assignment concealed from patients and staff until recruitment was complete? | Yes = 1, No = 0, Unclear = 0 |
| 32. Was there adequate adjustment for confounding in the analyses from which main findings were drawn? | Yes = 1, No = 0, Unclear = 0 |
| 33. Were losses of patients to follow-up taken into account? | Yes = 1, No = 0, Unclear = 0 |
| 34. Are attempts made to use intention-to-treat analysis or similarly robust methods to manage losses to follow up? a
| Yes = 2, Partially = 1, Unclear = 0, No = 0 |
|
| |
| 35. Was the study sufficiently powered to detect clinically important effects where probability value for a difference due to chance is <5%? | Yes = 1, No = 0, Unclear = 0 |
a denotes additional or modified questions for the purposes of this systematic review. b additional question added from MINORS [98]. Total possible for RCT: 38. Total possible for non-randomised with comparator/control group: 35. Total possible for non-randomised with no comparator/control group: 28. Score ranges are given corresponding quality levels: excellent (35–38); good (26–34); fair (21–25); and poor (≤19) modified from [60] quality level ratings.